OmniaSecure defibrillation lead safety study
Part of Heart & circulation clinical trials.
This study follows patients who have or will receive the OmniaSecure defibrillation lead to see how well it works and how reliable it is over time. If you have this lead, you may be able to help researchers understand its long-term performance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are scheduled to get an OmniaSecure defibrillation lead
- You (or your legal representative) must sign a consent form before or within 30 days of getting the lead
- You may have already been enrolled in the LEADR Pivotal study and are continuing here
- You must be able to attend follow-up visits and not be enrolled in other studies that could affect these results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how well certain Medtronic heart devices work over the long term. You may be included if you have a qualifying Medtronic implant and the research team can reliably get your implant and follow-up information.
This trial tests the safety and early performance of the Xtrac O.S. system, a new tool designed to remove old pacemaker or defibrillator leads. It may help patients who need their leads taken out after being in place for 1 to 5 years.
This study keeps a long-term record of people who get an ICD (a device that helps treat dangerous heart rhythms) and its lead. It may help doctors learn how ICD leads perform over time.
This study checks how well specific MicroPort CRM heart devices and leads work in real life over time. If you already have one of these FDA/market-approved implants and can be followed yearly, the study helps the company monitor safety and performance.
This study tests a new type of defibrillator that goes underneath the skin, near your breastbone, to protect against dangerous heart rhythms. It may be an option if you need an ICD but haven't had certain prior chest surgeries or devices.
This study collects information from adults who have been prescribed the ASSURE wearable defibrillator. The goal is to understand how the device performs in real-world patients after it is approved.
Hear when a new Tachyarrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.